Treatment approaches for children with Tourette's syndrome

Current Neurology and Neuroscience Reports

Volumn 3, Issue 2, 2003, Pages 143-148

  Lavenstein, Bennett L ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BACLOFEN; BOTULINUM TOXIN; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; CLOZAPINE; DESIPRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPHENAZINE; GUANFACINE; HALOPERIDOL; IMIPRAMINE; METHYLPHENIDATE; NICOTINE; NORTRIPTYLINE; OLANZAPINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SELEGILINE; TETRABENAZINE; TIAPRIDE; TIOTIXENE; TOPIRAMATE; TRIFLUOPERAZINE; UNINDEXED DRUG; VALPROIC ACID; ZIPRASIDONE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

AGRANULOCYTOSIS; ALPHA ADRENERGIC RECEPTOR BLOCKING; ALPHA ADRENERGIC STIMULATION; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CHILDHOOD DISEASE; COMORBIDITY; CONFUSION; DOPAMINE RECEPTOR BLOCKING; DRUG EFFICACY; DRUG ERUPTION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG TOLERABILITY; ECG ABNORMALITY; EXTRAPYRAMIDAL SYMPTOM; GABAERGIC TRANSMISSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOTENSION; MUCOSA INFLAMMATION; NAUSEA; NEUROCHEMISTRY; NEUROLOGY; OBSESSIVE COMPULSIVE DISORDER; PSYCHIATRY; QT PROLONGATION; RETROSPECTIVE STUDY; REVIEW; SEDATION; SIDE EFFECT; SKIN IRRITATION; TRANSDERMAL PATCH; WEIGHT GAIN; BRAIN LEVEL; DRUG EFFECT; IMMUNOTHERAPY; METABOLISM; NEUROSURGERY; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZODIAZEPINES; BRAIN CHEMISTRY; CHILD; DOPAMINE AGENTS; HUMANS; IMMUNOTHERAPY; NEUROSURGICAL PROCEDURES; TOURETTE SYNDROME;

EID: 0038182590     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0066-1     Document Type: Review

References (30)

1. Leckman FJ, Cohen DJ, Goetz CG, Jankovic J: Tourette Syndrome. In Advances in Neurology, Vol 85. Edited by Cohen DJ, Jankovic J, Goetz CC. Philadelphia: Lippincott Williams & Wilkins; 2001:369-390.
2. Jankovic J: Tourette's syndrome. N Engl J Med 2001, 16:1184-1192.
3. Emilien G, Malaoteaux PM, Gevits M, Hoogenberg K: Dopamine receptors. Physiological understanding to therapeutic intervention potential. Pharmacol Ther 1999, 84:133-56.
4. Ernst M, Zametkin AJ, Jons PH, Matochik P: High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 1999, 38:86-94.
5. Goetz CG, Kampoliti K:Tourette Syndrome. Rating scales and quantitative assessment in tics. In Advances in Neurology, Vol 85. Edited by Cohen CG, Kampoliti K. Philadelphia: Lippincot Williams & Wilkins; 2001:31-42.
6. Lang AE: Tourette Syndrome: update on treatment of tics. In Advances in Neurology, Vol. 85. Edited by Cohen DJ, Jankovic J, Goetz CG. Philadelphia: Lippincott Williams & Wilkins; 2001:355-362.
7. Hunt RD, Arnsten AF, Asbell MD: An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995, 34:50-54.
8. Sallee FR, Nesbitt L, Jackson LC, et al.: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997, 154:1057-1062.
9. Jankovic J: Gilles de la Tourette syndrome. Curr Ther 1999, 51:915-919.
10. Jankovic J, Beach J: Long term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358-362.
11. Bruun RD, Budman CL: Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 1995, 57:29-31.
12. Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292-299.
13. Budman C, Gayer A, Lesser M, et al.: An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychol 2001, 62:290-294.
14. Parraga HC, Parraga ML: Quetiapine treatment in patients with Tourette syndrome. Can J Psychiatry 2001, 46:184-185.
15. Schmider J, Hoff P: Clozapine in Tourette's syndrome. J Clin Psychopharmacol 1998, 18:88-89.
16. Singer HS, Wendlandt J, Krieger M: Baclofen treatment in Tourette syndrome: a double blind placebo controlled, crossover trial. Neurology 2001, 56:599-604.
17. Kwak CH, Hanna PA, Jankovic J: Botulinum treatment in the treatment of tics. Arch Neurol 2000, 57:1190-1193.
18. Marras C, Andrews D, Sime E, et al.: Botulinum toxin for the treatment of simple motor tics. Neurology 2001, 56:605-610.
19. Scott BL, lankovic J, Donovan DT: Botulinum injection into vocal cord in the treatment of malignant coproplalia associated with Tourettes syndrome. Mov Disorders 1996, 11:431-433.
20. Buzan RD, Sore J, O'Brien C, et al.: Obsessive compulsive disorder: current treatment options. Neurology 2000, 2:125-139.
21. Silver A, Shytle D, Phillip M, et al.: Transdermal nicotine and haloperidol in Tourette's Disorder: a double blind placebo controlled study. J Clin Psychiatry 2001, 62:707-714.
22. Gilbert D, Sethuram G, Sine L, et al.: Tourette's syndrome improvement with pergolide in a randomized double-blind, crossover trial. Neurology 2000, 54:1310-1315.
23. Anca M, Giladi N, Korczyn A: Ropinerole in Tourette's syndrome. Neurology 2001, 56:121.
24. Vanderwalle V, van der Linden G, Groenewegen HG, et al.: Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of the thalamus. Lancet 1999, 353:724.
25. Swedo SE, Leonard HE, Garvey M, et al.: Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections. Clinical description of first 50 cases. Am J Psychiatry 1998, 155:264-271.
26. Gadow KD, Sverd J, Sprakin J, et al.: Long term methylphenidate therapy in children with comorbid attention deficit disorder and chronic multiple motor tics. Arch Gen Psychiatry 1999, 56:330-336.
27. Hubt RD, Arnsten AF, Asbell MD, et al.: An open trial of guanfacine in the treatment of attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1995, 34:50-54.
28. Grados MM, Scahill L, Riddle MA: Pharmacotherapy in children and adolescents with obsessive compulsive disorder. Child Adolesc Psychiatry Clin North Am 1999, 8:617-634.
29. Peterson BS, Cohen DJ: The treatment of Tourette's syndrome, multimodal developmental intervention. J Clin Psychiatry 1998, 59:62-72.
30. Riddle MA, Carlson J: Clinical psychopharmacology for Tourette syndrome and associated disorders. Tourette Syndrome. In Advances in Neurology, vol. 85. Edited by Cohen. Philadelphia: Lippincott, Williams & Wilkins; 2001:343-354.